SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of August 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on August 10, 2018. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists primarily of cover page information and an exhibit index referencing a press release (Exhibit 99.1), but the financial data within that press release is not included in the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are present in the provided content.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the form header, signature block, and exhibit index.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Press Release) to obtain the actual financial or operational updates intended by this filing.
- Confirm the registrant's identity as Hexindai Inc., noting the discrepancy with the "Akso Health Group" name in the request metadata.
- Check the filing date of August 10, 2018, against the reporting period of August 2018 to ensure timely disclosure.
- Review the company's Form 20-F annual reports for comprehensive financial statements, as this 6-K does not contain them.